在治疗前列腺癌时卡巴西塔克塞尔的有效性:系统性审查和元分析
Hashim Talib Hashim1, Mudassir Ahmad Khan2, Safa Irfan Shah3
1College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq.
American journal of men's health
|October 5, 2024
概括
卡巴西塔克塞尔改善了先前用多塞塔克塞尔治疗的转移性割抵抗性前列腺癌 (mCRPC) 患者的生存率和应答率. 然而,与其他治疗相比,它与发生严重不良事件的风险更高有关.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 转移性割抵抗性前列腺癌 (mCRPC) 是一个重大的治疗挑战,特别是在多塞治疗后进展的患者中.
- 卡巴西塔克塞尔是一种第二代分类物,其向微管动力学,以抑制癌细胞增殖并诱导细胞亡.
研究的目的:
- 系统地审查和元分析cabazitaxel在以前接受过dcetaxel治疗的mCRPC患者的疗效和安全性.
- 为了比较cabazitaxel和比较疗法之间的无进展生存率 (PFS),总生存率 (OS) 和治疗响应率.
主要方法:
- 使用来自多个数据库的数据进行了系统审查和元分析,包括CENTRAL,PubMed,MEDLINE,Web of Science,Embase和Scopus.
- 随机对照试验 (RCT) 的偏差风险使用Cochrane ROB2工具进行评估,并使用RevMan软件进行分析.
主要成果:
- 与对照治疗相比,Cabazitaxel显著改善了PFS (HR 0.77 [0.61, 0.97]) 和OS (HR 0.79 [0.70, 0.88]) 的情况.
- 观察到卡巴西塔克塞尔的治疗反应率有利,包括PSA降低反应 (PRR) (OR = 1.59 [0.56, 4.52]) 和瘤反应率 (TRR) (OR = 2.34 [1.28, 4.28]).
- 卡巴西塔克塞尔与严重不良事件的发生率显著增加有关 (RR 1.64 [1.14,2.35]).
结论:
- 卡巴西塔克塞尔在基于多塞塔克塞尔的治疗中进展的mCRPC患者中提供了显著的生存益处和改善的应答率.
- 卡巴西塔克塞尔严重不良事件的风险增加需要对患者进行仔细的监测和管理.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


